Task: Answer the MCQ question.
Question: Which compound exhibits a -12.751% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
[a] CCN(C(=O)CCS(=O)(=O)c1cccc2nsnc12)c1cccc(C)c1
[b] CC1(C)CC(=O)c2sc(NC(=O)Cc3cccs3)nc2C1
Answer: a. CCN(C(=O)CCS(=O)(=O)c1cccc2nsnc12)c1cccc(C)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN(C(=O)CCS(=O)(=O)c1cccc2nsnc12)c1cccc(C)c1
CCN(C(=O)CCS(=O)(=O)c1cccc2nsnc12)c1cccc(C)c1
3-(2,1,3-benzothiadiazol-4-ylsulfonyl)-N-ethyl-N-(3-methylphenyl)propanamide